QIKcap System™ *
U.S. Patent 10,610,609
The First and Only FDA Granted - Ultraviolet light-based microbial reduction device for luer-activated valves.
The QIKCAP Device, used in conjunction with the single-use QIKCAP Cap, is a UVC treatment device intended to supplement manual needle-free luer connector instructions to 'scrub the hub' with CHG/IPA wipes. After conducting the protocol in the needle-free connector instructions for use, the QIKCAP Device applies UVC to the connector septum for 10 seconds to assist in reducing microbial contamination. The single use QIKCAP Cap also functions as a physical barrier, helping protect the connector from environmental contamination for up to 7 days if not removed.
Under the conditions of testing, the combined use of an 3.15% CHG/70% IPA wipes applied for a 5 seconds and the QIKCAP Device resulted in 4-log reductions in Staphylococcus aureus, Klebsiella pneumoniae, Staphylococcus epidermidis, and Enterobacter cloacae. The device has not shown a significant reduction in fungal organisms. A correlation to clinical infection-related outcomes has not been established.
The QIKcap Device™ (QD™) is the only device designed for needleless IV connectors that delivers:
Superior UVC Technology
UVC technology
Automated Irradiation Dose
Ease of use
Rapid Point of Care IV port microbial reduction
Innovative Design
Handheld, Lightweight, Ergonomic design
Responsive Technology with Tactile Confirmation
Device and Disposable Format
Verifiable Chromatic dosimeter
This is a prescription device restricted to sale by or on the order of a licensed practitioner, in compliance with 21 CFR 801.109